The global Corticosteroid API market size is predicted to grow from US$ 2662 million in 2025 to US$ 3828 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.
Corticosteroid Active Pharmaceutical Ingredients (APIs) refer to the active components used in the synthesis of corticosteroid drugs. These compounds belong to the steroid hormone class and mimic the effects of adrenal cortex hormones in the human body. They are widely used for anti-inflammatory, immunosuppressive, anti-allergic, and endocrine treatments. Common corticosteroid APIs include Prednisone, Dexamethasone, Betamethasone, and Hydrocortisone. These APIs are extensively utilized in the pharmaceutical industry for manufacturing oral tablets, injections, ointments, and inhalation formulations. Due to their potent pharmacological effects and complex production processes, the global market is primarily dominated by a few major pharmaceutical companies and high-end Contract Manufacturing Organizations (CMOs), with China and India playing significant roles in the industry.
The corticosteroid API market has maintained stable growth in recent years, driven primarily by the sustained demand for anti-inflammatory, immunosuppressive, and endocrine-related treatments in the global pharmaceutical industry. These APIs are widely used in the treatment of dermatological conditions, respiratory diseases, autoimmune disorders, and ophthalmic diseases. Major players in the market include multinational pharmaceutical companies and specialized API manufacturers, resulting in a relatively concentrated competitive landscape. However, fluctuations in raw material costs, stricter environmental regulations, and changes in international trade policies continue to introduce uncertainties in the supply chain.
The market is expected to continue growing due to rising chronic disease prevalence, advancements in new formulations, and the expansion of the generic drug sector. Emerging markets in Asia and Latin America are likely to drive further industry development as pharmaceutical demand surges. Additionally, improvements in green manufacturing processes, the application of biosynthesis technology, and the optimization of regulatory frameworks will contribute to a more sustainable and efficient industry. At the same time, increasing demand for high-purity APIs with lower impurities will push for higher industry standards and compliance requirements.
Key drivers of market growth include the rigid global demand for pharmaceuticals, the expansion of the generic drug industry, and cost optimizations through technological advancements. However, several challenges persist, such as rising production costs due to stringent environmental policies, trade barriers affecting raw material supply chains, and long, capital-intensive development cycles for high-end products. Additionally, intense price competition, particularly in the low-end market, may pressure profit margins. Moving forward, the industry will need to focus on product innovation, production efficiency, and regulatory compliance to sustain growth.
The 鈥淐orticosteroid API Industry Forecast鈥� looks at past sales and reviews total world Corticosteroid API sales in 2024, providing a comprehensive analysis by region and market sector of projected Corticosteroid API sales for 2025 through 2031. With Corticosteroid API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corticosteroid API industry.
This Insight Report provides a comprehensive analysis of the global Corticosteroid API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Corticosteroid API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Corticosteroid API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corticosteroid API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corticosteroid API.
This report presents a comprehensive overview, market shares, and growth opportunities of Corticosteroid API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Other
Segmentation by Application:
Injectable Drugs
Oral Drugs
Topical Drugs
Inhaled Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Teva Pharmaceutical Industries
Hovione
Axplora
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Wellona Pharma
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Guangdong Vtr Bio-Tech
Zhejiang Xianju Xianle Pharmaceutical
TIANJIN PACIFIC PHARMACEUTICAL
Shandong Xinhua Pharmaceutica Group
Jiangsu Lianhuan Pharmaceutical
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Saituo Biological Technology
Zhejiang Xianju Junye Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Corticosteroid API market?
What factors are driving Corticosteroid API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Corticosteroid API market opportunities vary by end market size?
How does Corticosteroid API break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Corticosteroid API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Corticosteroid API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Corticosteroid API by Country/Region, 2020, 2024 & 2031
2.2 Corticosteroid API Segment by Type
2.2.1 Prednisone Series
2.2.2 Dexamethasone Series
2.2.3 Betamethasone Series
2.2.4 Hydrocortisone Series
2.2.5 Other
2.3 Corticosteroid API Sales by Type
2.3.1 Global Corticosteroid API Sales Market Share by Type (2020-2025)
2.3.2 Global Corticosteroid API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Corticosteroid API Sale Price by Type (2020-2025)
2.4 Corticosteroid API Segment by Application
2.4.1 Injectable Drugs
2.4.2 Oral Drugs
2.4.3 Topical Drugs
2.4.4 Inhaled Drugs
2.5 Corticosteroid API Sales by Application
2.5.1 Global Corticosteroid API Sale Market Share by Application (2020-2025)
2.5.2 Global Corticosteroid API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Corticosteroid API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Corticosteroid API Breakdown Data by Company
3.1.1 Global Corticosteroid API Annual Sales by Company (2020-2025)
3.1.2 Global Corticosteroid API Sales Market Share by Company (2020-2025)
3.2 Global Corticosteroid API Annual Revenue by Company (2020-2025)
3.2.1 Global Corticosteroid API Revenue by Company (2020-2025)
3.2.2 Global Corticosteroid API Revenue Market Share by Company (2020-2025)
3.3 Global Corticosteroid API Sale Price by Company
3.4 Key Manufacturers Corticosteroid API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Corticosteroid API Product Location Distribution
3.4.2 Players Corticosteroid API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Corticosteroid API by Geographic Region
4.1 World Historic Corticosteroid API Market Size by Geographic Region (2020-2025)
4.1.1 Global Corticosteroid API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Corticosteroid API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Corticosteroid API Market Size by Country/Region (2020-2025)
4.2.1 Global Corticosteroid API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Corticosteroid API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Corticosteroid API Sales Growth
4.4 APAC Corticosteroid API Sales Growth
4.5 Europe Corticosteroid API Sales Growth
4.6 Middle East & Africa Corticosteroid API Sales Growth
5 Americas
5.1 Americas Corticosteroid API Sales by Country
5.1.1 Americas Corticosteroid API Sales by Country (2020-2025)
5.1.2 Americas Corticosteroid API Revenue by Country (2020-2025)
5.2 Americas Corticosteroid API Sales by Type (2020-2025)
5.3 Americas Corticosteroid API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Corticosteroid API Sales by Region
6.1.1 APAC Corticosteroid API Sales by Region (2020-2025)
6.1.2 APAC Corticosteroid API Revenue by Region (2020-2025)
6.2 APAC Corticosteroid API Sales by Type (2020-2025)
6.3 APAC Corticosteroid API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Corticosteroid API by Country
7.1.1 Europe Corticosteroid API Sales by Country (2020-2025)
7.1.2 Europe Corticosteroid API Revenue by Country (2020-2025)
7.2 Europe Corticosteroid API Sales by Type (2020-2025)
7.3 Europe Corticosteroid API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Corticosteroid API by Country
8.1.1 Middle East & Africa Corticosteroid API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Corticosteroid API Revenue by Country (2020-2025)
8.2 Middle East & Africa Corticosteroid API Sales by Type (2020-2025)
8.3 Middle East & Africa Corticosteroid API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Corticosteroid API
10.3 Manufacturing Process Analysis of Corticosteroid API
10.4 Industry Chain Structure of Corticosteroid API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Corticosteroid API Distributors
11.3 Corticosteroid API Customer
12 World Forecast Review for Corticosteroid API by Geographic Region
12.1 Global Corticosteroid API Market Size Forecast by Region
12.1.1 Global Corticosteroid API Forecast by Region (2026-2031)
12.1.2 Global Corticosteroid API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Corticosteroid API Forecast by Type (2026-2031)
12.7 Global Corticosteroid API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer CentreOne
13.1.1 Pfizer CentreOne Company Information
13.1.2 Pfizer CentreOne Corticosteroid API Product Portfolios and Specifications
13.1.3 Pfizer CentreOne Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer CentreOne Main Business Overview
13.1.5 Pfizer CentreOne Latest Developments
13.2 EUROAPI
13.2.1 EUROAPI Company Information
13.2.2 EUROAPI Corticosteroid API Product Portfolios and Specifications
13.2.3 EUROAPI Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 EUROAPI Main Business Overview
13.2.5 EUROAPI Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Corticosteroid API Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Teva Pharmaceutical Industries
13.4.1 Teva Pharmaceutical Industries Company Information
13.4.2 Teva Pharmaceutical Industries Corticosteroid API Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Pharmaceutical Industries Main Business Overview
13.4.5 Teva Pharmaceutical Industries Latest Developments
13.5 Hovione
13.5.1 Hovione Company Information
13.5.2 Hovione Corticosteroid API Product Portfolios and Specifications
13.5.3 Hovione Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hovione Main Business Overview
13.5.5 Hovione Latest Developments
13.6 Axplora
13.6.1 Axplora Company Information
13.6.2 Axplora Corticosteroid API Product Portfolios and Specifications
13.6.3 Axplora Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Axplora Main Business Overview
13.6.5 Axplora Latest Developments
13.7 Steroid SpA
13.7.1 Steroid SpA Company Information
13.7.2 Steroid SpA Corticosteroid API Product Portfolios and Specifications
13.7.3 Steroid SpA Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Steroid SpA Main Business Overview
13.7.5 Steroid SpA Latest Developments
13.8 Avik Pharmaceutical
13.8.1 Avik Pharmaceutical Company Information
13.8.2 Avik Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.8.3 Avik Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Avik Pharmaceutical Main Business Overview
13.8.5 Avik Pharmaceutical Latest Developments
13.9 Anuh Pharma
13.9.1 Anuh Pharma Company Information
13.9.2 Anuh Pharma Corticosteroid API Product Portfolios and Specifications
13.9.3 Anuh Pharma Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Anuh Pharma Main Business Overview
13.9.5 Anuh Pharma Latest Developments
13.10 Symbiotec Pharmalab
13.10.1 Symbiotec Pharmalab Company Information
13.10.2 Symbiotec Pharmalab Corticosteroid API Product Portfolios and Specifications
13.10.3 Symbiotec Pharmalab Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Symbiotec Pharmalab Main Business Overview
13.10.5 Symbiotec Pharmalab Latest Developments
13.11 Sun Pharmaceutical
13.11.1 Sun Pharmaceutical Company Information
13.11.2 Sun Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.11.3 Sun Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sun Pharmaceutical Main Business Overview
13.11.5 Sun Pharmaceutical Latest Developments
13.12 Cipla
13.12.1 Cipla Company Information
13.12.2 Cipla Corticosteroid API Product Portfolios and Specifications
13.12.3 Cipla Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Cipla Main Business Overview
13.12.5 Cipla Latest Developments
13.13 Wellona Pharma
13.13.1 Wellona Pharma Company Information
13.13.2 Wellona Pharma Corticosteroid API Product Portfolios and Specifications
13.13.3 Wellona Pharma Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wellona Pharma Main Business Overview
13.13.5 Wellona Pharma Latest Developments
13.14 Tianjin Tianyao Pharmaceuticals
13.14.1 Tianjin Tianyao Pharmaceuticals Company Information
13.14.2 Tianjin Tianyao Pharmaceuticals Corticosteroid API Product Portfolios and Specifications
13.14.3 Tianjin Tianyao Pharmaceuticals Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tianjin Tianyao Pharmaceuticals Main Business Overview
13.14.5 Tianjin Tianyao Pharmaceuticals Latest Developments
13.15 Zhejiang Xianju Pharmaceutical
13.15.1 Zhejiang Xianju Pharmaceutical Company Information
13.15.2 Zhejiang Xianju Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.15.3 Zhejiang Xianju Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.15.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.16 Guangdong Vtr Bio-Tech
13.16.1 Guangdong Vtr Bio-Tech Company Information
13.16.2 Guangdong Vtr Bio-Tech Corticosteroid API Product Portfolios and Specifications
13.16.3 Guangdong Vtr Bio-Tech Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Guangdong Vtr Bio-Tech Main Business Overview
13.16.5 Guangdong Vtr Bio-Tech Latest Developments
13.17 Zhejiang Xianju Xianle Pharmaceutical
13.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
13.17.2 Zhejiang Xianju Xianle Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.17.3 Zhejiang Xianju Xianle Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zhejiang Xianju Xianle Pharmaceutical Main Business Overview
13.17.5 Zhejiang Xianju Xianle Pharmaceutical Latest Developments
13.18 TIANJIN PACIFIC PHARMACEUTICAL
13.18.1 TIANJIN PACIFIC PHARMACEUTICAL Company Information
13.18.2 TIANJIN PACIFIC PHARMACEUTICAL Corticosteroid API Product Portfolios and Specifications
13.18.3 TIANJIN PACIFIC PHARMACEUTICAL Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 TIANJIN PACIFIC PHARMACEUTICAL Main Business Overview
13.18.5 TIANJIN PACIFIC PHARMACEUTICAL Latest Developments
13.19 Shandong Xinhua Pharmaceutica Group
13.19.1 Shandong Xinhua Pharmaceutica Group Company Information
13.19.2 Shandong Xinhua Pharmaceutica Group Corticosteroid API Product Portfolios and Specifications
13.19.3 Shandong Xinhua Pharmaceutica Group Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Shandong Xinhua Pharmaceutica Group Main Business Overview
13.19.5 Shandong Xinhua Pharmaceutica Group Latest Developments
13.20 Jiangsu Lianhuan Pharmaceutical
13.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
13.20.2 Jiangsu Lianhuan Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.20.3 Jiangsu Lianhuan Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Jiangsu Lianhuan Pharmaceutical Main Business Overview
13.20.5 Jiangsu Lianhuan Pharmaceutical Latest Developments
13.21 Shanghai New Hualian Pharmaceutical
13.21.1 Shanghai New Hualian Pharmaceutical Company Information
13.21.2 Shanghai New Hualian Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.21.3 Shanghai New Hualian Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Shanghai New Hualian Pharmaceutical Main Business Overview
13.21.5 Shanghai New Hualian Pharmaceutical Latest Developments
13.22 Shandong Taihua Biotech
13.22.1 Shandong Taihua Biotech Company Information
13.22.2 Shandong Taihua Biotech Corticosteroid API Product Portfolios and Specifications
13.22.3 Shandong Taihua Biotech Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Shandong Taihua Biotech Main Business Overview
13.22.5 Shandong Taihua Biotech Latest Developments
13.23 Saituo Biological Technology
13.23.1 Saituo Biological Technology Company Information
13.23.2 Saituo Biological Technology Corticosteroid API Product Portfolios and Specifications
13.23.3 Saituo Biological Technology Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Saituo Biological Technology Main Business Overview
13.23.5 Saituo Biological Technology Latest Developments
13.24 Zhejiang Xianju Junye Pharmaceutical
13.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
13.24.2 Zhejiang Xianju Junye Pharmaceutical Corticosteroid API Product Portfolios and Specifications
13.24.3 Zhejiang Xianju Junye Pharmaceutical Corticosteroid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Zhejiang Xianju Junye Pharmaceutical Main Business Overview
13.24.5 Zhejiang Xianju Junye Pharmaceutical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
